ForteBio

ForteBio is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences. ForteBio develops analytical systems that enable real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. ForteBio utilizes proprietary Bio-Layer Interferometry (BLI)) to create self-calibrating, simple-to-use, and inexpensive instruments that streamline measuring molecular interactions. An entire analysis can be completed in minutes and does not require labeling of the probe or the target. ForteBio's analytical capabilities provide greater value in applications where existing methods (e.g., HPLC, ELISA, and surface plasmon resonance) have limitations in throughput, performance and cost.